SAMD10 inhibitors represent a class of compounds that selectively interact with and modulate the activity of the SAMD10 protein, a member of the sterile alpha motif domain-containing family. SAMD10 is a relatively under-explored protein, but it is known to be involved in various intracellular signaling pathways, especially those related to cellular differentiation, proliferation, and apoptosis. Inhibitors of SAMD10 typically function by binding to specific regions of the protein, thus disrupting its normal conformational dynamics and hindering its ability to facilitate key biological processes. The inhibition mechanism often involves either competitive binding to the protein's active sites or allosteric modulation that affects its overall structural integrity and interactions with other molecular entities within the cell. This class of inhibitors is of great interest in the study of fundamental cellular biology due to its potential to unravel complex regulatory networks where SAMD10 plays a role.
Chemically, SAMD10 inhibitors can be quite diverse in structure, incorporating a range of functional groups that enhance their binding affinity and specificity for the SAMD10 protein. Many of these compounds are designed based on small-molecule scaffolds that allow for high flexibility in terms of chemical modification, enabling researchers to fine-tune their molecular properties, such as solubility, stability, and specificity. The structural features of these inhibitors typically include heterocyclic cores, aromatic rings, and polar substituents that promote interactions with the protein's active or regulatory sites. Some may also be designed to act as covalent inhibitors, forming stable bonds with specific amino acid residues in SAMD10. In terms of application, SAMD10 inhibitors are critical in experimental settings for dissecting the functional roles of SAMD10 in various biological pathways, providing insights into its regulatory functions in the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that could influence the degradation of ubiquitinated proteins. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor used in cancer therapy, might affect SAMD10-related pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor, which could affect gene expression, potentially influencing SAMD10. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor, used in cancer therapy, might affect SAMD10-related pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, could impact signaling pathways, potentially affecting SAMD10. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which might indirectly affect proteins involved in cell growth and survival. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits autophagy and lysosomal degradation, potentially affecting protein turnover related to SAMD10. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Inhibits Wnt/β-catenin signaling, potentially affecting SAMD10-related processes. | ||||||